Continuous renal replacement therapy in critically ill patients with acute on chronic liver failure and acute kidney injury: A retrospective cohort study

2020 ◽  
Vol 93 (4) ◽  
pp. 187-194 ◽  
Author(s):  
Ivan E. Saraiva ◽  
Victor M. Ortiz-Soriano ◽  
Xiaonan Mei ◽  
Fabiola G. Gianella ◽  
Winnie Sheu Woc ◽  
...  
2021 ◽  
Author(s):  
Khalid Al Sulaiman ◽  
Abdulrahman Alshaya ◽  
Amjad Alsaeed ◽  
Nadiyah Alshehri ◽  
Ramesh Vishwakarma ◽  
...  

Abstract BackgroundVancomycin is a commonly used antibiotic in critically ill patients for various indications. Critical illness imposes pharmacokinetic-pharmacodynamics challenges which makes optimizing vancomycin in this population cumbersome. Data are scarce on the clinical impact of time to therapeutic trough levels of vancomycin in critically ill patients. Objective (s)The aim of this study to evaluate the timing to achieve therapeutic trough level vancomycin on 30-day mortality in critically ill patients.SettingAdult critically ill patients admitted to intensive care units (ICUs) between January 1st, 2017 and December 31st, 2018 at a tertiary teaching hospital.MethodA retrospective cohort study for all adult critically ill patients aged 18 years or older with confirmed gram-positive infection and received vancomycin. We compared early (<48 hours) versus late (≥ 48 hours) attainment of vancomycin therapeutic trough levels. Main outcomesPrimary outcome was the 30-day mortality in critically ill patients. Secondary outcomes were development of resistant organisms, eradicating microorganisms within 4-5 days of vancomycin initiation, vancomycin-induced acute kidney injury (AKI), and ICU LOS. ResultsTwo hundred and nine patients were included. No significant differences between comparative groups in baseline characteristics. Achieving therapeutic levels were associated with better survival at 30 days (OR: 0.48; 95% CI [0.26-0.87]; p<0.01). Additionally, patients who achieved therapeutic levels of vancomycin early were less likely to develop resistant organisms (OR=0.08; 95% CI [0.01-0.59]; p=0.01). Acute kidney injury (AKI) and ICU length of stay (LOS) were not significant between the two groups.ConclusionEarly attainment of vancomycin therapeutic levels was associated with possible survival benefit.


Nephron ◽  
2016 ◽  
Vol 133 (4) ◽  
pp. 239-246 ◽  
Author(s):  
Trijntje J.W. Rennie ◽  
Andrea Patton ◽  
Tobias Dreischulte ◽  
Samira Bell

2021 ◽  
pp. 1-13
Author(s):  
Raghavan Murugan ◽  
Samantha J. Kerti ◽  
Chung-Chou H. Chang ◽  
Martin Gallagher ◽  
Ary Serpa Neto ◽  
...  

<b><i>Introduction:</i></b> Higher net ultrafiltration (UF<sub>NET</sub>) rates are associated with mortality among critically ill patients with acute kidney injury (AKI) and treated with continuous renal replacement therapy (CRRT). <b><i>Objective:</i></b> The aim of the study was to discover whether UF<sub>NET</sub> rates are associated with renal recovery and independence from renal replacement therapy (RRT). <b><i>Methods:</i></b> Retrospective cohort study using data from the Randomized Evaluation of Normal versus Augmented Level of Renal Replacement Therapy trial that enrolled 1,433 critically ill patients with AKI and treated with CRRT between December 2005 and November 2008 across 35 intensive care units in Australia and New Zealand. We examined the association between UF<sub>NET</sub> rate and time to independence from RRT by day 90 using competing risk regression after accounting for mortality. The UF<sub>NET</sub> rate was defined as the volume of fluid removed per hour adjusted for patient body weight. <b><i>Results and Conclusions:</i></b> Median age was 67.3 (interquartile range [IQR], 57–76.3) years, 64.4% were male, median Acute Physiology and Chronic Health Evaluation-III score was 100 (IQR, 84–118), and 634 (44.2%) died by day 90. Kidney recovery occurred in 755 patients (52.7%). Using tertiles of UF<sub>NET</sub> rates, 3 groups were defined: high, &#x3e;1.75; middle, 1.01–1.75; and low, &#x3c;1.01 mL/kg/h. Proportion of patients alive and independent of RRT among the groups were 47.8 versus 57.2 versus 53.0%; <i>p</i> = 0.01. Using competing risk regression, higher UF<sub>NET</sub> rate tertile compared with middle (cause-specific hazard ratio [csHR], 0.79, 95% CI, 0.66–0.95; subdistribution hazard ratio [sHR], 0.80, 95% CI, 0.67–0.97) and lower (csHR, 0.69, 95% CI, 0.56–0.85; sHR, 0.78, 95% CI 0.64–0.95) tertiles were associated with a longer time to independence from RRT. Every 1.0 mL/kg/h increase in rate was associated with a lower probability of kidney recovery (csHR, 0.81, 95% CI, 0.74–0.89; and sHR, 0.87, 95% CI, 0.80–0.95). Using the joint model, longitudinal increases in UF<sub>NET</sub> rates were also associated with a lower renal recovery (β = −0.29, <i>p</i> &#x3c; 0.001). UF<sub>NET</sub> rates &#x3e;1.75 mL/kg/h compared with rates 1.01–1.75 and &#x3c;1.01 mL/kg/h were associated with a longer duration of dependence on RRT. Randomized clinical trials are required to confirm this UF<sub>NET</sub> rate-outcome relationship.


Sign in / Sign up

Export Citation Format

Share Document